Guidance maps clearance process for trials of knee cartilage products

01/20/2012 | MassDevice.com (Boston)

New guidance from the FDA outlines the process for obtaining clearance for clinical studies of devices, combination products and biologics designed to replace or repair knee cartilage. The guidance requires manufacturers seeking investigational device exemption to submit documents describing materials used, individual elements, anticipated product changes and related data.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC